| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
8,098,231 | 8,748,842 | 5,340,240 | 4,817,220 | 4,988,150 |
| Cost of Revenue
|
-6,012,588 | -6,729,639 | -3,522,157 | -2,884,084 | -3,166,317 |
|
Gross Profit
|
2,085,643 | 2,019,203 | 1,818,083 | 1,933,136 | 1,821,833 |
|
Operating Income/Expenses
|
-1,753,179 | -1,555,706 | -1,767,790 | -1,880,487 | -1,897,192 |
|
Total Operating Profit/Loss
|
332,464 | 463,497 | 50,293 | 52,649 | -75,359 |
| Total Net Finance Income/Expense
|
9,324 | 7,311 | -6,089 | -6,572 | -7,168 |
| Net Investment Income
|
-2,496 | -2,026 | 525 | 1,069 | 10,144 |
| Irregular Income/Expenses
|
-6,779 | 23,590 | 82,973 | 111,358 | -34,269 |
|
Other Income/Expense, Non-Operating
|
-1,648 | -939 | -13,123 | -2,816 | 6,275 |
|
Non-Operating Income/Expenses, Total
|
2,480 | 27,936 | 64,286 | 103,039 | -25,018 |
|
Pretax Income
|
334,944 | 491,433 | 114,579 | 155,687 | -100,376 |
| Provision for Income Tax
|
-41,581 | -50,855 | -50,161 | -42,110 | -10,806 |
|
Net Income from Continuing Operations
|
293,363 | 440,578 | 64,418 | 113,577 | -111,182 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
293,361 | 440,577 | 64,417 | 113,576 | -111,182 |
|
Non-Controlling/Minority Interests
|
-- | -- | -- | 0 | 3,364 |
|
Net Income after Non-Controlling/Minority Interests
|
293,361 | 440,577 | 64,417 | 113,576 | -107,817 |
|
Net Income Available to Common Stockholders
|
293,361 | 440,577 | 64,417 | 113,576 | -107,817 |
|
Diluted Net Income Available to Common Stockholders
|
293,361 | 440,577 | 64,417 | 113,576 | -107,817 |
| Basic EPS
|
6.75 | 10.17 | 1.63 | 3.31 | -3.31 |
| Diluted EPS
|
7.68 | 10.17 | 1.63 | 3.31 | -3.31 |
|
Basic Weighted Average Shares Outstanding
|
43,581.55 | 43,321.24 | 39,519.63 | 34,312.99 | 32,573.11 |
|
Diluted Weighted Average Shares Outstanding
|
43,581.60 | 43,321.24 | 39,519.63 | 34,312.99 | 32,584.77 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
327,601 | 484,122 | 115,829 | 162,259 | -93,208 |
|
EBITDA
|
475,905 | 606,475 | 150,730 | 180,367 | -63,217 |
|
Normalized EBITDA
|
483,244 | 584,911 | 252 | 42,300 | -39,092 |
|
Normalized Income
|
343,885 | 479,805 | 47,563 | 44,291 | -74,510 |
|
Total Unusual Items
|
7,339 | -21,564 | -150,478 | -138,067 | 24,125 |
|
Total Unusual Items Excluding Goodwill
|
7,339 | -21,564 | -150,478 | -138,067 | 24,125 |
|
Tax Effect of Unusual Items
|
911.09 | -2,231.51 | -34,910.90 | -37,344.22 | 5,597 |
12/31/2022 - 10/10/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade